Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (11): 1253-1256.

Previous Articles     Next Articles

Comparison of drugs effect on MHV-A59 virus by established DBT cell model

FU Hong-yan, Xu Bo, WANG Hong-jun1, GONG Ze-hui   

  1. Institute of Pharmacology and Toxicology,the Academy of Military Medical Sciences,Beijing 100850,China;
    1Shenyang OasisPharmaceutical Manufacturing CO,LTD,Shenyang 110016,Liaoning,China
  • Received:2005-08-17 Revised:2005-09-27 Online:2005-11-26 Published:2020-11-12

Abstract: AIM: To establish sensitive DBT cell model to MHV-A59 by virology method,and develoPse-lective method of anti virus drugs in cell level.METHODS: Test 50% percent tissue culture infective dose(TCID50)by cytopathetic effect(CPE)and plaque meth-ods.Preparation of antibody against virus by partially pu-rified virus immunized animal.Selective anti virus drug adding 100 fold of TICD50virus dose infected DBT cell as positive results by protesting lower50%CPE,and tested drugs lowest virus inhibit concentration.RESULTS: Pre-pared antibody has specificity reverse virus action,and new synthesized drugs had various degree protective ac-tions to virus infective.CONCLUSION: The DBT cell model sensitive to MHV-A59 can select anti coronaviruses drug.

Key words: MHV-A59, DBT cell, TCID50, ELISA, antibody

CLC Number: